Scarborough Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-62
Closed -$5.62K 726
2026
Q1
$5.62K Hold
62
﹤0.01% 512
2025
Q4
$5.58K Hold
62
﹤0.01% 306
2025
Q3
$6.12K Hold
62
﹤0.01% 289
2025
Q2
$5.67K Buy
+62
New +$6K ﹤0.01% 283
2024
Q3
Sell
-62
Closed -$6.74K 471
2024
Q2
$6.74K Hold
62
﹤0.01% 233
2024
Q1
$8.2K Hold
62
﹤0.01% 217
2023
Q4
$7.56K Buy
+62
New +$6.92K ﹤0.01% 419

Other funds holding ZBH

Scarborough Advisors's ZBH Position: Q2 2026 in Review

Scarborough Advisors sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 62 shares — an estimated $5.62K sold.

Scarborough Advisors first reported a position in ZBH in Q4 2023 and held it in 7 quarters. The position peaked at $8.2K in Q1 2024. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Scarborough Advisors reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
  • Scarborough Advisors sold 62 Zimmer Biomet shares in Q2 2026, an estimated $5.62K.
  • Scarborough Advisors first reported a position in Zimmer Biomet in Q4 2023 and held it in 7 quarters.
  • Scarborough Advisors's Zimmer Biomet position peaked at $8.2K in Q1 2024.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.